The SS+T2DM group had higher HbA1c and blood glucose levels on admission than the T2DM group, but no significant difference was detected in white blood cell count, lymphocyte count, Hs-CRP, APACH II score, SOFA score, and 28-day mortality between the SS and SS+T2DM groups. This evidence concerns the gene CRP and type 2 diabetes mellitus.